Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators

Circulation Journal

Volumn 72, Issue 1, 2008, Pages 102-105

  Chang, Hoon Lee ^a   Nam, Gi Byoung ^a   Park, Hyun Gu ^a   Hyung, Yong Kim ^a   Park, Kyoung Min ^a   Kim, Jun ^a   Choi, Kee Joon ^a   Kim, You Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Amiodarone; Implantable cardioverter defibrillator

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL; ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LUNG DIFFUSION CAPACITY; LUNG INFILTRATE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; SIDE EFFECT; THERAPY EFFECT; THYROID FUNCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTRIC INJURY; HEART ATRIUM FIBRILLATION; HEART FAILURE; LUNG DISEASE; MIDDLE AGED; SHOCK;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC INJURIES; FEMALE; HEART FAILURE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; SHOCK; SOTALOL;

EID: 39849086874     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.102     Document Type: Article

References (14)

1. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
3. Luderitz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993; 16: 1815-1821.
4. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
5. Curtis AB. Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. J Am Coll Cardiol 2004; 43: 44-46.
6. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol: d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999; 340: 1855-1862.
7. Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tatla DS, et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004; 110: 3646-3654.
8. Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 2003; 8: 215-220.
9. Hreybe H, Ezzeddine R, Barrington W, Bazaz R, Jain S, Ngwu O, et al. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks. Am J Cardiol 2006; 97: 544-546.
10. Schaumann A, von zur Muhlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol 1996; 78: 42-50.
11. Boriani G, Occhetta E, Pistis G, Menozzi C, Jorfida M, Sermasi S, et al. Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002; 25: 1357-1366.
12. The CASCADE study. Cardiac Arrest in Seattle: Conventional versus Amiodarone Drug Evaluation. Am J Cardiol 1991; 67: 578-584.
13. Satomi K, Kurita T, Takatsuki S, Yokoyama Y, Chinushi M, Tsuboi N, et al. Amiodarone therapy in patients implanted with cardioverterdefibrillator for life-threatening ventricular arrhythmias. Circ J 2006; 70: 977-984.
14. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA 2006; 295: 165-171.